Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India News
NEW DELHI: The Centre has issued a detailed advisory on the use, risks and regulation of GLP-1 receptor agonist drugs, as their popularity grows for treating type 2 diabetes and obesity.According to PIB, these drugs, commonly prescribed to regulate blood sugar and aid weight loss—must be used strictly under medical supervision due to potential side…